drug
as of 2026-07-01Tiagabine
MeSH D000078308
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Beth Israel Deaconess Medical Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT00179465Phase 3Active Not Recruiting
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here